Inquiry into allergies and anaphylaxis

The House of Representatives Standing Committee on Health, Aged Care and Sport will inquire into and report on:

1. The potential and known causes, prevalence, impacts and costs of anaphylaxis in Australia;
2. The adequacy of food and drug safety process and food and drug allergy management, auditing and compliance (including food allergen labelling by manufacturers and food service providers);
3. The adequacy and consistency of professional education, training, management/treatment standards and patient record systems for allergy and anaphylaxis;
4. Access to and cost of services, including diagnosis, testing, management, treatment and support;
5. Developments in research into allergy and anaphylaxis including prevention, causes, treatment and emerging treatments (such as oral immunotherapy);
6. Unscientific diagnosis and treatments being recommended and used by some consumers; and
7. The impact of unnecessary drug avoidance due to unconfirmed drug allergies and its management, such drug allergy ‘de-labelling’.